Baxter International (BAX)

Baxter International (NYSE:BAX) raised its full-year 2026 outlook after reporting third-quarter sales and adjusted earnings that exceeded its expectations, citing broad-based growth across its portfolio, improving execution and strong free cash flow generation. Third-quarter global sales totaled ab

Revenue hit $3 billion with 5% organic growth; guidance raised on momentum.

Healthcare company Baxter International (NYSE:BAX) reported Q3 2026 results beating Wall Street’s revenue expectations, with revenue up 5% year on year to $2...

Healthcare company Baxter International (NYSE:BAX) will be announcing earnings results this Thursday before market hours. Here’s what you need to know. Baxte...

Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built the...

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor exec...

What Happened? Shares of healthcare company Baxter International (NYSE:BAX) fell 3.8% in the afternoon session after the U.S. Food and Drug Administration pu...

As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - diversifi...

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...

A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be...

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only reali...

Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built the...

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad t...

As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare equipment and supplies indu...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a...

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...

Baxter has had an impressive run over the past six months as its shares have beaten the S&P 500 by 14.5%. The stock now trades at $27.42, marking a 26.2% gai...